These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 26685433)

  • 1. Training and certification to perform urine studies.
    MLO Med Lab Obs; 2015 Nov; 47(11):49. PubMed ID: 26685433
    [No Abstract]   [Full Text] [Related]  

  • 2. Development of a clinically relevant liquid chromatography tandem mass spectrometry assay for 13 drugs of abuse in urine, designed to meet the needs of the service users.
    Duxbury K; Romagnoli C; Anderson M; Watts R; Waite G
    Ann Clin Biochem; 2010 Sep; 47(Pt 5):415-22. PubMed ID: 20595401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Body packing.
    Dueñas-Laita A; Nogué S; Burillo-Putze G
    N Engl J Med; 2004 Mar; 350(12):1260-1; author reply 1260-1. PubMed ID: 15028835
    [No Abstract]   [Full Text] [Related]  

  • 4. [Education and Training of Personnel in Morphology].
    Katagiri H; Yamagata J
    Rinsho Byori; 2016 Feb; 64(2):162-7. PubMed ID: 27311280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid screening of drugs of abuse and their metabolites by gas chromatography/mass spectrometry: application to urinalysis.
    Strano-Rossi S; Molaioni F; Rossi F; Botrè F
    Rapid Commun Mass Spectrom; 2005; 19(11):1529-35. PubMed ID: 15880665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [On-site testing for drug abuse in urine].
    Espnes KA; Spigset O; Delaveris GJ; Mørland J; Smith-Kielland A
    Tidsskr Nor Laegeforen; 2006 Sep; 126(17):2257-60. PubMed ID: 16967064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of a novel immunoassay for the detection of synthetic cannabinoids and metabolites in urine specimens.
    Arntson A; Ofsa B; Lancaster D; Simon JR; McMullin M; Logan B
    J Anal Toxicol; 2013 Jun; 37(5):284-90. PubMed ID: 23625703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adulterants and drugs-of- abuse testing: an update.
    Dasgupta A
    MLO Med Lab Obs; 2008 Feb; 40(2):24-5. PubMed ID: 18405221
    [No Abstract]   [Full Text] [Related]  

  • 9. Drugs of abuse in urine: some pitfalls in testing.
    Bosomworth MP
    Br J Biomed Sci; 1993 Jun; 50(2):150-5. PubMed ID: 8219920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The subversion of urine drug testing.
    Berge KH; Bush DM
    Minn Med; 2010 Aug; 93(8):45-7. PubMed ID: 20862879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The utility of immunoassays for urine drug testing.
    Melanson SE
    Clin Lab Med; 2012 Sep; 32(3):429-47. PubMed ID: 22939301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Framework for leadership and training of Biosafety Level 4 laboratory workers.
    Le Duc JW; Anderson K; Bloom ME; Estep JE; Feldmann H; Geisbert JB; Geisbert TW; Hensley L; Holbrook M; Jahrling PB; Ksiazek TG; Korch G; Patterson J; Skvorak JP; Weingartl H
    Emerg Infect Dis; 2008 Nov; 14(11):1685-8. PubMed ID: 18976549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of adulterants on urine screen for drugs of abuse: detection by an on-site dipstick device.
    Wong R
    Am Clin Lab; 2002; 21(1):37-9. PubMed ID: 11975450
    [No Abstract]   [Full Text] [Related]  

  • 14. Urine drug screening and the family physician.
    Floren AE
    Am Fam Physician; 1994 May; 49(6):1441-7. PubMed ID: 8172041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of a urine on-site drugs of abuse screening test in patients admitted to a psychiatric emergency unit.
    Bagøien G; Morken G; Zahlsen K; Aamo T; Spigset O
    J Clin Psychopharmacol; 2009 Jun; 29(3):248-54. PubMed ID: 19440078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simulation of drug use and urine screening patterns.
    Crosby RD; Carlson GA; Specker SM
    J Addict Dis; 2003; 22(3):89-98. PubMed ID: 14621347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cut-off and toxicity levels for drugs-of-abuse testing.
    MLO Med Lab Obs; 2003 Aug; 35(8 Suppl):8-9. PubMed ID: 12964303
    [No Abstract]   [Full Text] [Related]  

  • 18. Implementation of point-of-care rapid urine testing for drugs of abuse in the emergency department of an academic medical center: impact on test utilization and ED length of stay.
    Lewandrowski K; Flood J; Finn C; Tannous B; Farris AB; Benzer TI; Lee-Lewandrowski E
    Am J Clin Pathol; 2008 May; 129(5):796-801. PubMed ID: 18426741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A clinical laboratory automation system for drugs-of-abuse monitoring.
    Passarelli J; Bates M
    Am Clin Lab; 1997 Sep; 16(8):8-9. PubMed ID: 10174263
    [No Abstract]   [Full Text] [Related]  

  • 20. Urine drug testing for social service agencies in Nova Scotia, Canada.
    Fraser AD
    J Forensic Sci; 1998 Jan; 43(1):194-6. PubMed ID: 9456542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.